Translate

Κυριακή 16 Αυγούστου 2020

 


Contemporary management of pancreas cancer in older people
Publication date: Available online 15 August 2020Source: European Journal of Surgical OncologyAuthor(s): Minas Baltatzis, Maria Grazia Rodriquenz, Ajith K. Siriwardena, Nicola De Liguori Carino
European Journal of Surgical Oncology (EJSO)
Sun Aug 16, 2020 17:11
The progression of non-small cell lung cancer from diagnosis to surgery
Publication date: Available online 15 August 2020Source: European Journal of Surgical OncologyAuthor(s): Iain McPherson, Nicholas A. Bradley, Rohith Govindraj, Ewan D. Kennedy, Alan J. Kirk, Mohammed Asif
European Journal of Surgical Oncology (EJSO)
Sun Aug 16, 2020 17:11
Event-free survival in Desmoid-Type fibromatosis (DTF): A pre-post comparison of upfront surgery versus wait-and-see approach
Publication date: Available online 15 August 2020Source: European Journal of Surgical OncologyAuthor(s): Laura Ruspi, Ferdinando Carlo Maria Cananzi, Federico Sicoli, Laura Samà, Salvatore Lorenzo Renne, Andrea Marrari, Nicolò Gennaro, Piergiuseppe Colombo, Luca Cozzaglio, Letterio Salvatore Politi, Alexia Bertuzzi, Vittorio Quagliuolo
European Journal of Surgical Oncology (EJSO)
Sat Aug 15, 2020 16:03
Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients
Publication date: Available online 14 August 2020Source: European Journal of Surgical OncologyAuthor(s): Jia Ke, Xuan-hui Liu, Xiao-feng Jiang, Zhen He, Jian Xiao, Bin Zheng, Yu-feng Chen, Ze-rong Cai, Xiao-bin Zheng, Yi-feng Zou, Ping Lan, Xiao-jian Wu, Feng Gao
European Journal of Surgical Oncology (EJSO)
Sat Aug 15, 2020 16:03
Announcements
Publication date: September 2020Source: European Journal of Surgical Oncology, Volume 46, Issue 9Author(s):
European Journal of Surgical Oncology (EJSO)
Fri Aug 14, 2020 20:04
Corrigendum to “The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases in a single center” [Eur. J. Surg. Oncol. 46/3 (2019) 402–409]
Publication date: September 2020Source: European Journal of Surgical Oncology, Volume 46, Issue 9Author(s): Oktar Asoglu, Handan Tokmak, Baris Bakir, Gokhan Demir, Enis Ozyar, Banu Atalar, Suha Goksel, Burak Koza, Aslihan Guven Mert, Atakan Demir, Koray Guven
European Journal of Surgical Oncology (EJSO)
Fri Aug 14, 2020 20:04
Does the difficulty grade of laparoscopic liver resection for colorectal liver metastases correlate with long-term outcomes?
Publication date: September 2020Source: European Journal of Surgical Oncology, Volume 46, Issue 9Author(s): Wacław Hołówko, Ioannis Triantafyllidis, Maud Neuberg, Nicolas Tabchouri, Marc Beaussier, Mostefa Bennamoun, Anthony Sarran, Marine Lefevre, Christophe Louvet, Brice Gayet, David Fuks
European Journal of Surgical Oncology (EJSO)
Fri Aug 14, 2020 20:04
The efficacy and safety of the open approach irreversible electroporation in the treatment of pancreatic cancer: A systematic review
Publication date: September 2020Source: European Journal of Surgical Oncology, Volume 46, Issue 9Author(s): Pabos Charalambous, Dimitrios Moris, Georgia-Sofia Karachaliou, Alexandros Papalampros, Nikolaos Dimitrokallis, Diamantis I. Tsilimigras, Dimitrios Oikonomou, Athanasios Petrou
European Journal of Surgical Oncology (EJSO)
Fri Aug 14, 2020 20:04
Editorial Board
Publication date: September 2020Source: European Journal of Surgical Oncology, Volume 46, Issue 9Author(s):
European Journal of Surgical Oncology (EJSO)
Fri Aug 14, 2020 20:04
Calendar
Publication date: September 2020Source: European Journal of Surgical Oncology, Volume 46, Issue 9Author(s):
European Journal of Surgical Oncology (EJSO)
Fri Aug 14, 2020 20:04
Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without Hyperthermic IntraPEritoneal Chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations — Part II: Postoperative Management and Special Considerations
Publication date: Available online 13 August 2020Source: European Journal of Surgical OncologyAuthor(s): Martin Hübner, Shigeki Kusamura, Laurent Villeneuve, Ahmed Al-Niaimi, Mohammad Alyami, Konstantin Balonov, John Bell, Robert Bristow, Delia Cortés Guiral, Anna Fagotti, Luiz Fernando R. Falcão, Olivier Glehen, Laura Lambert, Lloyd Mack, Tino Muenster, Pompiliu Piso, Marc Pocard, Beate Rau, Olivia Sgarbura, S.P. Somashekkar
European Journal of Surgical Oncology (EJSO)
Fri Aug 14, 2020 20:04
POLARIS: a prospective, multicenter, noninterventional study assessing palbociclib in hormone receptor-positive advanced breast cancer.
POLARIS: a prospective, multicenter, noninterventional study assessing palbociclib in hormone receptor-positive advanced breast cancer. Future Oncol. 2020 Aug 13;: Authors: Tripathy D, Blum JL, Rocque GB, Bardia A, Karuturi MS, Cappelleri JC, Liu Y, Zhang Z, Davis KL, Wang Y Abstract This report describes the rationale, purpose and design of the POLARIS study. POLARIS is an ongoing noninterventional, prospective, multicenter study. Female and...
Future Oncology.
Fri Aug 14, 2020 16:38
Clinical efficacy, predictive biomarkers and response patterns of immunotherapy combinations for patients with cancer.
Related Articles Clinical efficacy, predictive biomarkers and response patterns of immunotherapy combinations for patients with cancer. Future Oncol. 2020 Aug;16(23):1659-1664 Authors: Recondo G, Mezquita L PMID: 32783513 [PubMed - in process]
Future Oncology.
Fri Aug 14, 2020 16:38
Sorafenib treatment by Child-Pugh score in Latin American patients with hepatocellular carcinoma.
Related Articles Sorafenib treatment by Child-Pugh score in Latin American patients with hepatocellular carcinoma. Future Oncol. 2020 Aug 12;: Authors: de Guevara LL, Dagher L, Arruda VM, Nakajima K, Kudo M Abstract Aim: To evaluate sorafenib treatment in Latin American patients with unresectable hepatocellular carcinoma in the real-world GIDEON study. Patients and methods: Sorafenib administration, safety and efficacy were analyzed by Child-Pugh...
Future Oncology.
Fri Aug 14, 2020 16:38
Reply to: Comments on "Cost of decentralized CAR T cell production in an academic non‐profit setting”
International Journal of Cancer
Sat Aug 15, 2020 12:45
Comments on “Cost of decentralized CAR T cell production in an academic non‐profit setting”
International Journal of Cancer
Sat Aug 15, 2020 12:45
Comments on “Survival Impact of Adjuvant Chemotherapy in Patients With Stage IIA Colon Cancer: Analysis of the National Cancer Database”
International Journal of Cancer
Sat Aug 15, 2020 11:43
Reply to: Comments on <Survival Impact of Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer: Analysis of the National Cancer Database>
International Journal of Cancer
Sat Aug 15, 2020 11:43
Long-Term Psychosocial Well-Being and Quality of Life Among Childhood Cancer Survivors Who Developed a Subsequent Malignant Neoplasm
Journal of Adolescent and Young Adult Oncology, Ahead of Print.
Journal of Adolescent and Young Adult Oncology
Fri Aug 14, 2020 10:00
Clinical Predictive Factors of Response to Treatment in Patients Undergoing Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer
Journal of Adolescent and Young Adult Oncology, Ahead of Print.
Journal of Adolescent and Young Adult Oncology
Fri Aug 14, 2020 10:00
Quality of the patient-oriented web-based information on esophageal cancer
Abstract This study was aimed to analyze the readability and quality of patient education websites on esophageal cancer. Yahoo!, Google, and Bing search engines were searched using keywords esophageal cancer, esophageal tumor, esophageal tumor, esophageal malignancy, esophageal cancer, esophageal tumor, esophageal tumor, and esophageal malignancy. The first 50 websites resulting in each keyword search were evaluated using validated FRES, LIDA, and DISCERN scores to assess readability,...
Journal of Cancer Education
Sat Aug 15, 2020 03:00
CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis
Colorectal cancer (CRC) is one of the causes of cancer-related death worldwide. The aim of our study was to disclose the expression pattern and underlying molecular mechanism of circular RNA TADA2A (circTADA2A...
Journal of Experimental & Clinical Cancer Research - Latest Articles
Sat Aug 15, 2020 03:00
Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma
Emerging evidence has shown that dysregulated expression of long noncoding RNAs (lncRNAs) is implicated in liver hepatocellular carcinoma (HCC). However, the role and molecular mechanism of differentially expr...
Journal of Experimental & Clinical Cancer Research - Latest Articles
Fri Aug 14, 2020 03:00
TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1
Chemoresistance is emerging as a major barrier to successful treatment in acute myeloid leukemia (AML), and evasion of apoptosis is among the fundamental underlying mechanisms. Therefore, unraveling molecular ...
Journal of Experimental & Clinical Cancer Research - Latest Articles
Fri Aug 14, 2020 03:00
A SNP-mediated lncRNA (LOC146880) and microRNA (miR-539-5p) interaction and its potential impact on the NSCLC risk
Many cancer-associated single nucleotide polymorphisms (SNPs) are located in the genomic regions of long non-coding RNAs (lncRNAs). Mechanisms of these SNPs in connection to cancer risk are not fully understood.
Journal of Experimental & Clinical Cancer Research - Latest Articles
Fri Aug 14, 2020 03:00
SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain‐dependent regulation of Wnt/β‐catenin signaling
Abstract Sex‐determining region Y box (SOXs) are expressed in various cells and control cell fate and differentiation in a multitude of physiologic processes. SOX6, a main representative of SOXs, is involved in the regulation of carcinogenesis in various human malignancies. However, the role of SOX6 in clear cell renal cell carcinoma (ccRCC) remains unclear. In this study, SOX6 expression in ccRCC and its clinical significance were investigated. In vitro and in vivo assays were used to explore the...
Molecular Carcinogenesis
Fri Aug 14, 2020 12:55
Regulation of β-catenin by IGFBP2 and its cytoplasmic actions in glioma
Abstract Purpose IGFBP2 is one of the highly expressed genes in glioblastoma (GBM). It has both IGF dependent and independent activities. IGF independent actions are mediated by the activation of integrin signalling through its RGD motif present at C-terminal domain. One of the actions of IGFBP2 is to regulate β-catenin by the inactivation of GSK3β, which preferentially accumulates in the cytoplasm. The mechanism of nuclear β-catenin...
Neuro-Oncology
Sun Aug 16, 2020 03:00
Causes of death in pediatric neuro-oncology: the sickkids experience from 2000 to 2017
Abstract Purpose Primary benign and malignant central nervous system (CNS) tumors are the most frequent solid tumors in the pediatric age and represent the leading cause of death by cancer in children in high income countries. However, information regarding specific causes of death in this population is still limited. The objective of this work was to investigate mortality in a large cohort of children diagnosed at our institution....
Neuro-Oncology
Fri Aug 14, 2020 03:00
Oncometabolites and the response to radiotherapy
Radiotherapy (RT) is applied in 45–60% of all cancer patients either alone or in multimodal therapy concepts comprising surgery, RT and chemotherapy. However, despite technical innovations approximately only 5...
Radiation Oncology - Latest Articles
Fri Aug 14, 2020 03:00
Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma
Hepatocellular carcinoma (HCC) involving a major branch of the portal or hepatic vein is in a locally advanced stage and remains difficult to cure. This study aimed to evaluate the clinical effects of carbon i...
Radiation Oncology - Latest Articles
Fri Aug 14, 2020 03:00
Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial
Patients with resected oral cavity squamous cell carcinoma (OCSCC) are often treated with adjuvant radiation (RT) ± concomitant chemotherapy based on pathological findings. Standard RT volumes include all surg...
Radiation Oncology - Latest Articles
Fri Aug 14, 2020 03:00
Missed radiation therapy sessions in first three weeks predict distant metastasis and less favorable outcomes in surgically treated patients with oral cavity squamous cell carcinoma
We sought to investigate the prognostic impact of missed RT sessions in patients who had undergone surgery for oral cavity squamous cell carcinoma (OCSCC).
Radiation Oncology - Latest Articles
Fri Aug 14, 2020 03:00
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients
This study was an open-label, 2-arms, monocentric, randomized clinical trial comparing Xonrid®, a topical medical device, versus standard of care (SOC) in preventing and treating acute radiation dermatitis (AR...
Radiation Oncology - Latest Articles
Thu Aug 13, 2020 03:00
Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224)
A consistent association between the visualization of tumor hypoxia and a poor outcome after curatively intended radiotherapy has been demonstrated[1]. On the initiative of the Danish Head and Neck Cancer Group (DAHANCA), imaging of hypoxia was investigated in the DAHANCA 24 trial (Clinical Trials.gov Identifier NCT01017224) to determine its prognostic value in patients with head and neck squamous cell carcinoma (HNSCC)[2]. During 2009-2011, 40 patients were prospectively included in the study irrespective...
Radiotherapy and Oncology
Fri Aug 14, 2020 03:00
Apples and oranges: comparing partial breast irradiation techniques
Publication date: September–October 2020Source: Reports of Practical Oncology & Radiotherapy, Volume 25, Issue 5Author(s): Orit Kaidar-Person, Icro Meattini, Douglas Zippel, Philip Poortmans
Reports of Practical Oncology & Radiotherapy
Fri Aug 14, 2020 13:32
Termi-Luc: a versatile assay to monitor full-protein release from ribosomes [Method]
Termination of protein biosynthesis is an essential step of gene expression, during which a complete functional protein is released from the ribosome. Premature or inefficient termination results in truncated, non-functional or toxic proteins that may cause disease. Indeed, more than 10% of human genetic diseases are caused by nonsense mutations leading to premature termination. Efficient and sensitive approaches are required to study eukaryotic termination mechanisms and to identify potential therapeutics...
RNA In Advance
Fri Aug 14, 2020 19:28

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου

Translate